- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/22 - Ribonucleases
Patent holdings for IPC class C12N 9/22
Total number of patents in this class: 13895
10-year publication summary
|
410
|
631
|
797
|
1015
|
1134
|
1247
|
1510
|
1791
|
1684
|
320
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20473 |
584 |
| The Broad Institute, Inc. | 1918 |
539 |
| Massachusetts Institute of Technology | 10195 |
478 |
| President and Fellows of Harvard College | 6069 |
475 |
| The General Hospital Corporation | 4810 |
170 |
| Pairwise Plants Services, Inc. | 277 |
170 |
| Sangamo Therapeutics, Inc. | 407 |
166 |
| The Board of Trustees of the Leland Stanford Junior University | 6605 |
161 |
| CRISPR Therapeutics AG | 377 |
144 |
| Editas Medicine, Inc. | 255 |
142 |
| Arbor Biotechnologies Inc. | 168 |
141 |
| Cellectis | 409 |
138 |
| Pioneer Hi-Bred International, Inc. | 6812 |
137 |
| Beam Therapeutics Inc. | 259 |
131 |
| Regeneron Pharmaceuticals, Inc. | 4571 |
128 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 281 |
127 |
| Duke University | 3169 |
122 |
| Novozymes A/S | 3350 |
120 |
| Precision Biosciences, Inc. | 196 |
118 |
| EmendoBio Inc. | 144 |
109 |
| Other owners | 9595 |